Gastric Cancer
Supratek's lead compound SP1049C is granted Orphan Drug Designation for the treatment of gastric cancer.
Published in Medical Letter on the CDC and FDA, April 20th, 2008
Orphan drug refers to a product that is intended for use in a disease or condition that affects fewer than 200,000 individuals in the United States. According to the US National Cancer Institute it is estimated that 21,500 new cases of gastric cancer will be diagnosed in USA in 2008. Throughout the world, however, gastric cancer is the second leading cause of cancer-related deaths.
Last year Supratek Pharma obtained FDA clearance for its Investigational New Drug application for SP1049C for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Adverse Drug Reactions
Studies conducted at Hospital for Sick Children on adverse drug reactions recently published - Drug Development
Stanford Researcher Criticizes FDA Plans to Reduce Oversight of Off-Label Drug Use - Life Sciences
Data on life sciences described by G.J Kontoghiorghes et al - Life Sciences
New findings reported from Texas Southern University, Department of Chemistry describe advances in life sciences - Life Sciences
Research from Research Institute of Pharmaceutical Sciences, College of Pharmacy reveals new findings on life sciences - Monoclonal Antibodies
Scientists at University of Turin, Institute for Cancer Research and Treatment release new data on monoclonal antibodies - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
